Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Olive

Showing results (111-120 of 276) with videos related to

Pageof 28
Sort By:
Frontiers in Cellular and Infection Microbiology|July 23, 2016
Coxiella burnetii Induces Inflammatory Interferon-Like Signature in Plasmacytoid Dendritic Cells: A New Feature of Immune Response in Q FeverMignane B Ka, Soraya Mezouar, Amira Ben Amara, et al.
Leukemia & Lymphoma|December 25, 2003
Natural killer cell-triggering receptors in patients with acute leukaemiaCyril Fauriat, Emanuela Marcenaro, Simona Sivori, et al.
Journal of Medical Virology|February 18, 2011
Evaluation of type-specific HPV persistence and high-risk HPV viral load quantitation in HPV positive women under 30 with normal cervical cytologyXavier Carcopino, Noel Bolger, Mireille Henry, et al.
The Journal of Allergy and Clinical Immunology|July 4, 2016
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterizationSilvia Pesce, Marco Greppi, Giovanna Tabellini, et al.
Scientific Reports|July 2, 2024
DOK1 and DOK2 regulate CD8 T cell signaling and memory formation without affecting tumor cell killingVladimir Laletin, Pierre-Louis Bernard, Camille Montersino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 3, 2017
The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T CellsCassie-Marie Peigné, Alexandra Léger, Marie-Claude Gesnel, et al.
Oncology Reports|January 8, 2021
Selection of tumor‑resistant variants following sustained natural killer cell‑mediated immune stressThibault Carré, Jerome Thiery, Bassam Janji, et al.
Frontiers in Immunology|September 27, 2023
The immune checkpoint adenosine 2A receptor is associated with aggressive clinical outcomes and reflects an immunosuppressive tumor microenvironment in human breast cancerBasma Zohair, Dounia Chraa, Ibtissam Rezouki, et al.
Frontiers in Immunology|March 26, 2016
Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer CellsNicolas Dulphy, Anne-Sophie Chrétien, Zena Khaznadar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2009
Dok-4 is a novel negative regulator of T cell activationAudrey Gérard, Marguerite Ghiotto, Camille Fos, et al.
Pageof 28

Showing results (111-120 of 276) with videos related to

Sort By:
Pageof 28
Frontiers in Cellular and Infection Microbiology|July 23, 2016
Coxiella burnetii Induces Inflammatory Interferon-Like Signature in Plasmacytoid Dendritic Cells: A New Feature of Immune Response in Q FeverMignane B Ka, Soraya Mezouar, Amira Ben Amara, et al.
Leukemia & Lymphoma|December 25, 2003
Natural killer cell-triggering receptors in patients with acute leukaemiaCyril Fauriat, Emanuela Marcenaro, Simona Sivori, et al.
Journal of Medical Virology|February 18, 2011
Evaluation of type-specific HPV persistence and high-risk HPV viral load quantitation in HPV positive women under 30 with normal cervical cytologyXavier Carcopino, Noel Bolger, Mireille Henry, et al.
The Journal of Allergy and Clinical Immunology|July 4, 2016
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterizationSilvia Pesce, Marco Greppi, Giovanna Tabellini, et al.
Scientific Reports|July 2, 2024
DOK1 and DOK2 regulate CD8 T cell signaling and memory formation without affecting tumor cell killingVladimir Laletin, Pierre-Louis Bernard, Camille Montersino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 3, 2017
The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T CellsCassie-Marie Peigné, Alexandra Léger, Marie-Claude Gesnel, et al.
Oncology Reports|January 8, 2021
Selection of tumor‑resistant variants following sustained natural killer cell‑mediated immune stressThibault Carré, Jerome Thiery, Bassam Janji, et al.
Frontiers in Immunology|September 27, 2023
The immune checkpoint adenosine 2A receptor is associated with aggressive clinical outcomes and reflects an immunosuppressive tumor microenvironment in human breast cancerBasma Zohair, Dounia Chraa, Ibtissam Rezouki, et al.
Frontiers in Immunology|March 26, 2016
Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer CellsNicolas Dulphy, Anne-Sophie Chrétien, Zena Khaznadar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2009
Dok-4 is a novel negative regulator of T cell activationAudrey Gérard, Marguerite Ghiotto, Camille Fos, et al.
Pageof 28